mRNA |
AMG-706 |
FIMM |
pan-cancer |
AAC |
-0.055 |
0.7 |
mRNA |
lenvatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.7 |
mRNA |
SJ-172550 |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.7 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.7 |
mRNA |
ATRA |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.7 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.7 |
mRNA |
COL-3 |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.7 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.7 |
mRNA |
rigosertib |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.7 |
mRNA |
Curcumin |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.7 |